Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed MGMT Unmethylated Glioblastoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05879250
What this trial is testing

WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma, IDH-WildtypeMGMT-Unmethylated Glioblastoma
Northwestern University 39
Testing effectiveness (Phase 2)Looking for participantsNCT06991101
What this trial is testing

Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaBrain CancerGlioblastoma Multiforme+4 more
Baptist Health South Florida 190
Testing effectiveness (Phase 2)UnknownNCT05694416
What this trial is testing

Etoposide Plus Cisplatin Compared With Temozolomide in Patients With Glioblastoma

Who this might be right for
MGMT-Unmethylated Glioblastoma
Zhongnan Hospital 60
Very early researchNot Yet RecruitingNCT07778602
What this trial is testing

Safety and Feasibility of First-line Avutometinib and Defactinib in Patients With Newly Diagnosed High-grade Gliomas

Who this might be right for
MGMT-unmethylated Glioblastoma (GBM)IDH Wildtype Glioblastoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 22
Testing effectiveness (Phase 2)Looking for participantsNCT07476794
What this trial is testing

Daily Temozolomide for Elderly Patients With Unmethylated MGMT- Promoter Newly Diagnosed GliOblatoma

Who this might be right for
Glioblastoma
Sunnybrook Health Sciences Centre 118
Testing effectiveness (Phase 2)Study completedNCT03367715
What this trial is testing

Nivolumab, Ipilimumab, and Short-course Radiotherapy in Adults With Newly Diagnosed, MGMT Unmethylated Glioblastoma

Who this might be right for
MGMT-unmethylated Glioblastoma (GBM)GBM
NYU Langone Health 10
Testing effectiveness (Phase 2)Ended earlyNCT01044225
What this trial is testing

Effect of Radiation Therapy Plus Temozolomide Combined With Cilengitide or Cetuximab on the 1-year Overall Survival of Patients With Newly Diagnosed MGMT-promoter Unmethylated Glioblastoma

Who this might be right for
Glioblastoma
Bart Neyns 12
Large-scale testing (Phase 3)Active Not RecruitingNCT06388733
What this trial is testing

A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma

Who this might be right for
GlioblastomaGBMBrain Neoplasms, Adult, Malignant+1 more
Ivy Brain Tumor Center 450
Early research (Phase 1)Ended earlyNCT03250299
What this trial is testing

Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaMGMT-Unmethylated Glioblastoma
Basilea Pharmaceutica 26
Testing effectiveness (Phase 2)Looking for participantsNCT07185880
What this trial is testing

The Safety and Tolerability of MT-125 in GBM Patients

Who this might be right for
Glioblastoma (GBM)
Myosin Therapeutics Inc. 36
Testing effectiveness (Phase 2)Ended earlyNCT06359379
What this trial is testing

Ropidoxuridine as a Radiosensitizer in Newly Diagnosed IDH-Wildtype Glioblastoma With Unmethylated MGMT Promoter

Who this might be right for
Glioblastoma, IDH-wildtype
Shuttle Pharmaceuticals, Inc. 30
Early research (Phase 1)Active Not RecruitingNCT04555577
What this trial is testing

Phase I Trial of DNA-PK Inhibitor (PEPOSERTIB ) in Combination With Radiation and Adjuvant Temozolomide in Newly Diagnosed MGMT Unmethylated and Recurrent Glioblastoma

Who this might be right for
GlioblastomaGliosarcoma
M.D. Anderson Cancer Center 29
Testing effectiveness (Phase 2)UnknownNCT05033587
What this trial is testing

Study of AK105 With Anlotinib and Radiotherapy Adjuvant Therapy in MGMT Unmethylated Newly Diagnosed Glioblastoma.

Who this might be right for
MGMT-Unmethylated Glioblastoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 28
Large-scale testing (Phase 3)Study completedNCT02617589
What this trial is testing

An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)

Who this might be right for
Brain Cancer
Bristol-Myers Squibb 560
Testing effectiveness (Phase 2)Looking for participantsNCT05734560
What this trial is testing

D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients

Who this might be right for
Newly Diagnosed MGMT Unmethylated Glioblastoma
Darell Bigner 50
Early research (Phase 1)Active Not RecruitingNCT06973096
What this trial is testing

CART-EGFR-IL13Ra2 in Newly Diagnosed GBM Following Initial Radiotherapy

Who this might be right for
Glioblastoma
University of Pennsylvania 9